European Point of Care Diagnostic Testing Markets
TriMark Publications
September 1, 2011 298 Pages - SKU: TRI6521267
|
|
Countries covered: Europe
Point of care testing (POCT) enables diagnostic tests to be performed rapidly while the patient remains at the point of care facility, such as a hospital, health clinic, doctor's office or another near-patient venue. POCT is rapidly being recognized as a method of providing the results of the diagnostic tests immediately, rather than waiting hours or even days for outside lab results to arrive, thus improving patient outcomes. This report analyzes the European market for POCT products, a major component of the overall European in vitro diagnostics (IVD) category. This study reviews in detail the key sub-segments of the point of care diagnostics market including: blood glucose, blood gas and electrolytes, rapid coagulation, cardiac markers, substance abuse, infectious diseases, urine strip, pregnancy, fecal occult, cholesterol, and many others. For each of the individual sub-segments, this study examines the key market drivers and restraints, as well as evaluates the latest technological advances. The key feature of the review is a detailed analysis of the revenues, market growth rates and market share for the European market and for each of the selected geographic regions, which include: France, Germany, Italy, Spain, the U.K., the Benelux countries, Scandinavia and the Rest of Europe (ROE). The analysis surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the point of care market in the European market. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included.
|
- 1. Overview
- 1.1 About This Report
- 1.2 Scope of this Report
- 1.3 Methodology
- 1.4 Executive Summary
- 2. Background to the European Market for Point of Care Testing (POCT)
- 2.1 Background and Definition of Point of Care Testing
- 2.2 POCT Application Areas
- 2.2.1 POCT in the Primary Care Environment
- 2.2.2 POCT in the Operating Room
- 2.2.3 POCT in the Intensive Care Unit (ICU)
- 2.2.4 POCT in Accident and Emergency (A&E)
- 2.2.5 POCT in the Patient Transport Setting
- 2.2.6 POCT in the Home Environment
- 2.2.7 POCT in the Community
- 2.2.8 POCT in Sports Medicine
- 2.2.9 POCT in the Physician’s Office Laboratory (POL)/Home Care Clinic
- 2.3 Qualitative Market Analysis
- 2.3.1 Market Drivers
- 2.3.2 Market Restraints
- 2.3.3 Advantages of POCT
- 2.3.4 Disadvantages of POCT
- 2.4 Regulatory Environment, Issues and Challenges
- 2.5 Overview of the European Healthcare Systems
- 2.6 Procurement Process of Point of Care Testing Products
- 2.7 Secondary Care Structure and Organization within the E.U.
- 2.8 Product Pricing Policy and Issues
- 2.9 Technological Advances and Developments
- 2.9.1 Device Miniaturization and Microfluidic Technologies
- 2.9.2 Minimally Invasive and Non-Invasive POCT Technologies
- 2.9.3 Advances in Wireless Technologies
- 2.9.4 Automation of POCT
- 2.9.5 Developments in New Genomic Technologies (Genotyping, Haplotyping and Sequencing
- Technologies)
- 2.9.6 Advances in Informatics Technologies
- 2.9.7 Pharmacogenetic Testing
- 2.9.8 Multi Assay Technologies in POCT
- 2.10 Future Trends and Developments
- 3. The European Market for Blood Glucose POCT
- 3.1 Background to POC Blood Glucose Testing
- 3.2 Types of Blood Glucose Testing
- 3.2.1 Fasting Blood Sugar (FBS) or Fasting Plasma Glucose (FPG)
- 3.2.2 Two-Hour Postprandial Blood Sugar or Two-Hour PC
- 3.2.3 Random Blood Sugar (RBS)
- 3.2.4 Urine Glucose Test
- 3.2.5 Blood Glucose Test Strip
- 3.2.6 Glycosylated Hemoglobin (HbA1C)
- 3.2.7 Intravenous Glucose Tolerance Test (IVGTT)
- 3.2.8 Oral Glucose Tolerance Test (OGTT)
- 3.3 Segmentation of POC Blood Glucose Testing
- 3.3.1 Continuous Blood Glucose Monitoring (CBGM)
- 3.3.2 Self-Monitoring Blood Glucose (SMBG) Testing
- 3.3.3 Minimally Invasive and Non-Invasive Blood Glucose Testing
- 3.4 Emerging Glucose Monitoring Technologies
- 3.4.1 Optical Transducer Technologies
- 3.4.2 Transdermal Sensor Technologies
- 3.4.3 Invasive Glucose Sensor Technologies
- 3.5 Review of Selected POC Blood Glucose Monitoring Systems
- 3.6 Market Revenue Analysis
- 3.6.1 European Market Revenues Analysis
- 3.6.2 National Market Revenue Analysis
- 3.7 Market Share Analysis
- 3.7.1 European Market Share Analysis
- 3.7.2 European Market Share Analysis
- 4. The European Market for Blood Gas and Electrolyte POCT
- 4.1 Background to POC Blood Gas and Electrolyte Testing
- 4.1.1 Acid-base Balance and the Lungs
- 4.1.2 Respiratory Acidosis
- 4.1.3 Respiratory Alkalosis
- 4.1.4 Metabolic (or Non-Respiratory) Acidosis
- 4.1.5 Metabolic (or Non-Respiratory) Alkalosis
- 4.1.6 Increasing Popularity of POC Blood Gas and Electrolyte Testing
- 4.2 Market Segmentation
- 4.2.1 Types of Blood Gas Monitoring Equipment
- 4.2.1.1 Intermittent Blood Gas Monitoring Equipment
- 4.2.1.2 Continuous Blood Gas Monitoring Equipment
- 4.2.1.2.1 Extra-Arterial Blood Gas (EABG) Monitors
- 4.2.1.2.2 Intra-Arterial Blood Gas (IABG) Monitors
- 4.2.1.3 Portable, Blood Gas Analyzers
- 4.2.1.4 Patient Attached, On-Demand Blood Gas Analyzers
- 4.3 Applications for POCT Blood Gas and Electrolyte Analyzers
- 4.4 Qualitative Analysis
- 4.4.1 Market Drivers
- 4.4.2 Market Restraints
- 4.5 Emerging Technologies
- 4.6 Review of Selected Blood Gas and Electrolyte Analyzers
- 4.7 Market Revenue Analysis
- 4.7.1 European Market Revenues Analysis
- 4.7.2 National Market Revenue Analysis
- 4.8 Market Share Analysis
- 4.8.1 European Market Share Analysis
- 4.8.2 National Market Share Analysis
- 5. The European Market for Rapid Coagulation Testing
- 5.1 Background to Rapid Coagulation Testing
- 5.1.1 Hemostasis
- 5.1.2 Coagulation
- 5.1.2.1 The Intrinsic Pathway
- 5.1.2.2 The Extrinsic Pathway
- 5.1.3 Activation of Prothrombin to Thrombin
- 5.2 Blood Coagulation Tests
- 5.2.1 Bleeding Time Tests
- 5.2.2 Thrombin Time
- 5.2.3 The Prothrombin Time (PT) Test
- 5.2.4 The Partial Thromboplastin Time (PPT) Test
- 5.2.5 The Fibrinogen Test
- 5.2.6 Standard Test Results
- 5.3 Qualitative Analysis
- 5.3.1 Market Drivers
- 5.3.2 Market Restraints
- 5.4 Review of Selected POC Rapid Coagulation Analyzers
- 5.5 Market Revenue Analysis
- 5.5.1 European Market Revenue Analysis
- 5.5.2 National Market Revenue Analysis
- 5.6 Market Share Analysis
- 5.6.1 European Market Share Analysis
- 5.6.2 National Market Share Analysis
- 6. The European Market for POC Cardiac BioMarker Testing
- 6.1 Background to POC Cardiac Markers Testing
- 6.2 Cardiac Marker Tests
- 6.2.1 Creatine Kinase (CK)
- 6.2.2 Myoglobin
- 6.2.3 Cardiac Troponins T (TnT), I (TnI) and C (TnC)
- 6.2.4 C-reactive Protein (CRP)
- 6.2.5 Homocysteine
- 6.3 Emerging Markers
- 6.3.1 B-type Natriuretic Peptide (BNP)
- 6.3.2 Myeloperoxidase (MPO)
- 6.3.3 Ischemia Modified Albumin (IMA)
- 6.3.4 Glycogen Phosphorylase Isoenzyme BB (GPBB)
- 6.3.5 Fatty Acid-Binding Proteins (FABPs)
- 6.4 Qualitative Analysis
- 6.4.1 Market Drivers
- 6.4.2 Market Restraints
- 6.5 Review of Selected POC Cardiac Biomarkers Analyzers
- 6.6 Market Revenue Analysis
- 6.6.1 European Market Revenue Analysis
- 6.6.2 National Market Revenue Analysis
- 6.7 Market Share Analysis
- 6.7.1 European Market Share Analysis
- 6.7.2 National Market Share Analysis
- 7. The European Market for POC Substance Abuse Testing
- 7.1 Background to POC Substance Abuse Testing
- 7.2 Substance Abuse Test Types
- 7.2.1 Urine Substance/Drug Screening
- 7.2.2 Hair Tests for Substance Abuse and Screening
- 7.2.3 Blood Tests for Substance Abuse and Screening
- 7.2.4 Saliva Tests for Substance Abuse and Screening
- 7.2.5 Sweat Tests for Substance Abuse and Screening
- 7.2.6 Alcohol Abuse and Screening
- 7.3 Qualitative Analysis
- 7.3.1 Market Drivers
- 7.3.2 Market Restraints
- 7.4 Review of Selected POC Substance Abuse Analyzers
- 7.5 Market Revenue Analysis
- 7.5.1 European Market Revenue Analysis
- 7.5.2 National Market Revenue Analysis
- 7.6 Market Share Analysis
- 7.6.1 European Market Share Analysis
- 7.6.2 National Market Share Analysis
- 8. The European Market for POC Infectious Disease Testing
- 8.1 Background to POC Infectious Disease Testing
- 8.2 Types of Diagnosis for Infectious Diseases
- 8.2.1 Microbial Culture
- 8.2.2 Microscopy
- 8.2.3 Biochemical Tests
- 8.2.4 Molecular Diagnostics
- 8.3 Diagnostic Platforms for Infectious Diseases
- 8.3.1 Centralized Laboratory Testing for Infectious Diseases
- 8.3.2 POC Testing for Infectious Diseases
- 8.4 Emerging Technologies
- 8.5 Qualitative Analysis
- 8.5.1 Market Drivers
- 8.5.2 Market Restraints
- 8.6 Review of Selected POC Infectious Disease Testing Devices
- 8.7 Market Revenue Analysis
- 8.7.1 European Market Revenue Analysis
- 8.7.2 National Market Revenue Analysis
- 8.8 Market Share Analysis
- 8.8.1 European Market Share Analysis
- 8.8.2 National Market Share Analysis
- 9. The European Market for POC Urine Strip Testing
- 9.1 Background to POC Urine Strip Testing
- 9.2 Emerging Technologies
- 9.3 Review of Selected POC Urine Strip Testing
- 9.4 Market Revenue Analysis
- 9.4.1 European Market Revenue Analysis
- 9.4.2 National Market Revenue Analysis
- 9.5 Market Share Analysis
- 9.5.1 European Market Share Analysis
- 9.5.2 National Market Share Analysis
- 10. The European Market for POC Pregnancy Testing
- 10.1 Background to POC Pregnancy Testing
- 10.2 Review of Selected POC Pregnancy Testing Devices
- 10.3 Market Revenue Analysis
- 10.3.1 European Market Revenue Analysis
- 10.3.2 National Market Revenue Analysis
- 10.4 Market Share Analysis
- 10.4.1 European Market Share Analysis
- 10.4.2 National Market Share Analysis
- 11. The European Market for POC Fecal Occult Testing
- 11.1 Background to POC Fecal Occult Testing
- 11.2 Review of Selected POC Fecal Occult Testing Devices
- 11.3 Market Revenue Analysis
- 11.3.1 European Market Revenue Analysis
- 11.3.2 National Market Revenue Analysis
- 11.4 Market Share Analysis
- 11.4.1 European Market Share Analysis
- 11.4.2 National Market Share Analysis
- 12. The European Market for POC Cholesterol Testing
- 12.1 Background to POC Cholesterol Testing
- 12.2 POC Cholesterol Testing Devices
- 12.2.1 Review of Selected POC Cholesterol Testing Devices
- 12.2.2 Product Comparison of Leading Suppliers
- 12.2.3 Launch Dates of Leading Products in Europe
- 12.3 Market Revenue Analysis
- 12.3.1 European Market Revenue Analysis
- 12.3.2 National Market Revenue Analysis
- 12.4 Market Share Analysis
- 12.4.1 European Market Share Analysis
- 12.4.2 National Market Share Analysis
- 13. Profile of Leading Suppliers
- 13.1 Abaxis, Inc.
- 13.2 Abbott Laboratories
- 13.3 ACON Laboratories, Inc.
- 13.4 AgaMatrix, Inc.
- 13.5 Alere, Inc.
- 13.6 Bayer AG
- 13.7 LifeScan (Johnson & Johnson)
- 13.8 International Technidyne Corporation (ITC) Nexus Dx (Warburg Pincus, LLC)
- 13.9 NOVA Biomedical
- 13.10 F. Hoffman-La Roche Ltd.
- 13.11 A Menarini Diagnostics
- 13.12 Medtronic, Inc.
- 13.13 Radiometer Medical (Danaher Corporation)
- 13.14 Instrumentation Laboratory (IL)/Werfen Group
- 13.15 Siemens
- 14. Glossary of Abbreviations and Acronyms
- INDEX OF FIGURES
- Figure 2.1: Available forms of Connectivity Technology for POCT Devices
- Figure 2.2: Conformity Assessment Route, Annexes and Quality System Standards by IVD
- Device Category
- Figure 5.1: The Coagulation Cascade
- Figure 5.2: Coagulation Testing
- INDEX OF TABLES
- Table 1.1: European Revenue Analysis and Forecasts for POC Market, 2007-2017
- Table 1.2: Segment Revenue Analysis and Forecasts for POC Market, 2007-2017
- Table 1.3: European Revenue Forecasts for POC Market, 2007-2017
- Table 1.4: European Market Share Analysis for POC Market, 2010
- Table 2.1: Total Expenditure on Healthcare, Percentage GDP of Selected Countries, 2002-2008
- Table 2.2: Models of Public-Private Partnership in Hospital Provision
- Table 2.3: Common Genotype Techniques
- Table 3.1: Summary of Emerging Glucose Sensor Technologies, 2011
- Table 3.2: Selected POC Blood Glucose Monitoring Systems, 2011
- Table 3.3: European Revenue Forecasts for POC Blood Glucose Monitoring Systems, 2007-2017
- Table 3.4: National Revenue Forecasts by Country for POC Blood Glucose Monitoring Systems,
- 2007-2017
- Table 3.5: European Market Share Analysis for POC Blood Glucose Monitoring Systems, 2010
- Table 3.6: French Market Share Analysis for POC Blood Glucose Monitoring Systems, 2010
- Table 3.7: German Market Share Analysis for POC Blood Glucose Monitoring Systems, 2010
- Table 3.8: Italian Market Share Analysis for POC Blood Glucose Monitoring Systems, 2010
- Table 3.9: Spanish Market Share Analysis for POC Blood Glucose Monitoring Systems, 2010
- Table 3.10: U.K. Market Share Analysis for POC Blood Glucose Monitoring Systems, 2010
- Table 3.11: Benelux Market Share Analysis for POC Blood Glucose Monitoring Systems, 2010
- Table 3.12: Scandinavian Market Share Analysis for POC Blood Glucose Monitoring Systems, 2010
- Table 3.13: Rest-of-Europe Market Share Analysis for POC Blood Glucose Monitoring Systems, 2010
- Table 4.1: Selected POC Blood Gas and Electrolyte Analyzers, 2011
- Table 4.2: European Revenue Forecasts for POC Blood Gas Analysis Systems, 2007-2017
- Table 4.3: National Revenue Forecasts by Country for POC Blood Gas Analysis Systems, 2007-2017
- Table 4.4: European Market Share Analysis for POC Blood Gas Analysis Systems, 2010
- Table 4.5: French Market Share Analysis for POC Blood Gas Analysis Systems, 2010
- Table 4.6: German Market Share Analysis for POC Blood Gas Analysis Systems, 2010
- Table 4.7: Italian Market Share Analysis for POC Blood Gas Analysis Systems, 2010
- Table 4.8: Spanish Market Share Analysis for POC Blood Gas Analysis Systems, 2010
- Table 4.9: U.K. Market Share Analysis for POC Blood Gas Analysis Systems, 2010
- Table 4.10: Benelux Market Share Analysis for POC Blood Gas Analysis Systems, 2010
- Table 4.11: Scandinavian Market Share Analysis for POC Blood Gas Analysis Systems, 2010
- Table 4.12: Rest-of-Europe Market Share Analysis for POC Blood Gas Analysis Systems, 2010
- Table 5.1: Selected POC Rapid Coagulation Analyzers, 2011
- Table 5.2: European Revenue Forecasts for POC Rapid Coagulation Analyzer Systems, 2007-2017
- Table 5.3: National Revenue Forecasts by Country for POC Rapid Coagulation Analyzer Systems,
- 2007-2017
- Table 5.4: European Market Share Analysis for POC Rapid Coagulation Analyzer Systems, 2010
- Table 5.5: French Market Share Analysis for POC Rapid Coagulation Analyzer Systems, 2010
- Table 5.6: German Market Share Analysis for POC Rapid Coagulation Analyzer Systems, 2010
- Table 5.7: Italian Market Share Analysis for POC Rapid Coagulation Analyzer Systems, 2010
- Table 5.8: Spanish Market Share Analysis for POC Rapid Coagulation Analyzer Systems, 2010
- Table 5.9: U.K. Market Share Analysis for POC Rapid Coagulation Analyzer Systems, 2010
- Table 5.10: Benelux Market Share Analysis for POC Rapid Coagulation Analyzer Systems, 2010
- Table 5.11: Scandinavian Market Share Analysis for POC Rapid Coagulation Analyzer Systems, 2010
- Table 5.12: Rest-of-Europe Market Share Analysis for POC Rapid Coagulation Analyzer Systems, 2010
- Table 6.1: Selected POC Cardiac Biomarkers, 2011
- Table 6.2: European Revenue Forecasts for POC Cardiac Marker Devices, 2007-2017
- Table 6.3: National Revenue Forecasts by Country for POC Cardiac Marker Devices, 2007-2017
- Table 6.4: European Market Share Analysis for POC Cardiac Marker Devices, 2010
- Table 6.5: French Market Share Analysis for POC Cardiac Marker Devices, 2010
- Table 6.6: German Market Share Analysis for POC Cardiac Marker Devices, 2010
- Table 6.7: Italian Market Share Analysis for POC Cardiac Marker Devices, 2010
- Table 6.8: Spanish Market Share Analysis for POC Cardiac Marker Devices, 2010
- Table 6.9: U.K. Market Share Analysis for POC Cardiac Marker Devices, 2010
- Table 6.10: Benelux Market Share Analysis for POC Cardiac Marker Devices, 2010
- Table 6.11: Scandinavian Market Share Analysis for POC Cardiac Marker Devices, 2010
- Table 6.12: Rest-of-Europe Market Share Analysis for POC Cardiac Marker Devices, 2010
- Table 7.1: Selected POC Substance/Drug Abuse Testing Devices, 2011
- Table 7.2: European Revenue Forecasts for POC Substance/Drug Abuse Testing Device Market,
- 2007-2017
- Table 7.3: National Revenue Forecasts by Country for POC Substance/Drug Abuse Testing Device Market,
- 2007-2017
- Table 7.4: European Market Share Analysis for POC Substance/Drug Abuse Testing Device Market, 2010
- Table 7.5: French Market Share Analysis for POC Substance/Drug Abuse Testing Device Market, 2010
- Table 7.6: German Market Share Analysis for POC Substance/Drug Abuse Testing Device Market, 2010
- Table 7.7: Italian Market Share Analysis for POC Substance/Drug Abuse Testing Device Market, 2010
- Table 7.8: Spanish Market Share Analysis for POC Substance/Drug Abuse Testing Device Market, 2010
- Table 7.9: U.K. Market Share Analysis for POC Substance/Drug Abuse Testing Device Market, 2010
- Table 7.10: Benelux Market Share Analysis for POC Substance/Drug Abuse Testing Device Market, 2010
- Table 7.11: Scandinavian Market Share Analysis for POC Substance/Drug Abuse Testing Device Market,
- 2010
- Table 7.12: Rest-of-Europe Market Share Analysis for POC Substance/Drug Abuse Testing Device Market,
- 2010
- Table 8.1: Selected POC Infectious Disease Testing Devices, 2011
- Table 8.2: European Revenue Forecasts for POC Infectious Disease Testing Devices Market, 2007-2017
- Table 8.3: National Revenue Forecasts by Country for POC Infectious Disease Testing Devices Market,
- 2007-2017
- Table 8.4: European Market Share Analysis for POC Infectious Disease Testing Devices, 2010
- Table 8.5: French Market Share Analysis for POC Infectious Disease Testing Devices, 2010
- Table 8.6: German Market Share Analysis for POC Infectious Disease Testing Devices, 2010
- Table 8.7: Italian Market Share Analysis for POC Infectious Disease Testing Devices, 2010
- Table 8.8: Spanish Market Share Analysis for POC Infectious Disease Testing Devices, 2010
- Table 8.9: U.K. Market Share Analysis for POC Infectious Disease Testing Devices, 2010
- Table 8.10: Benelux Market Share Analysis for POC Infectious Disease Testing Devices, 2010
- Table 8.11: Scandinavian Market Share Analysis for POC Infectious Disease Testing Devices, 2010
- Table 8.12: Rest-of-Europe Market Share Analysis for POC Infectious Disease Testing Devices, 2010
- Table 9.1: Selected POC Urine Strip Testing, 2011
- Table 9.2: European Revenue Forecasts for POC Urine Strip Testing Products Market, 2007-2017
- Table 9.3: National Revenue Forecasts by Country for POC Urine Strip Testing Products Market,
- 2007-2017
- Table 9.4: European Market Share Analysis for POC Urine Strip Testing Products, 2010
- Table 9.5: French Market Share Analysis for POC Urine Strip Testing Products, 2010
- Table 9.6: German Market Share Analysis for POC Urine Strip Testing Products, 2010
- Table 9.7: Italian Market Share Analysis for POC Urine Strip Testing Products, 2010
- Table 9.8: Spanish Market Share Analysis for POC Urine Strip Testing Products, 2010
- Table 9.9: U.K. Market Share Analysis for POC Urine Strip Testing Products, 2010
- Table 9.10: Benelux Market Share Analysis for POC Urine Strip Testing Products, 2010
- Table 9.11: Scandinavian Market Share Analysis for POC Urine Strip Testing Products, 2010
- Table 9.12: Rest-of-Europe Market Share Analysis for POC Urine Strip Testing Products, 2010
- Table 10.1: Selected POC Pregnancy Testing Devices, 2011
- Table 10.2: European Revenue Forecasts for POC Pregnancy Testing Devices Market, 2007-2017
- Table 10.3: National Revenue Forecasts by Country for POC Pregnancy Testing Devices Market,
- 2007-2017
- Table 10.4: European Market Share Analysis for POC Pregnancy Testing Devices, 2010
- Table 10.5: French Market Share Analysis for POC Pregnancy Testing Devices, 2010
- Table 10.6: German National Market Share Analysis for POC Pregnancy Testing Devices, 2010
- Table 10.7: Italian Market Share Analysis for POC Pregnancy Testing Devices, 2010
- Table 10.8: Spanish Market Share Analysis for POC Pregnancy Testing Devices, 2010
- Table 10.9: U.K. Market Share Analysis for POC Pregnancy Testing Devices, 2010
- Table 10.10: Benelux Market Share Analysis for POC Pregnancy Testing Devices, 2010
- Table 10.11: Scandinavian Market Share Analysis for POC Pregnancy Testing Devices, 2010
- Table 10.12: Rest-of-Europe Market Share Analysis for POC Pregnancy Testing Devices, 2010
- Table 11.1: Selected POC Fecal Occult Testing Devices, 2011
- Table 11.2: European Revenue Forecasts for POC Fecal Occult Testing Devices Market, 2007-2017
- Table 11.3: National Revenue Forecasts by Country for POC Fecal Occult Testing Devices Market,
- 2007-2017
- Table 11.4: European Market Share Analysis for POC Fecal Occult Testing Devices, 2010
- Table 11.5: French Market Share Analysis for POC Fecal Occult Testing Devices, 2010
- Table 11.6: German Market Share Analysis for POC Fecal Occult Testing Devices, 2010
- Table 11.7: Italian Market Share Analysis for POC Fecal Occult Testing Devices, 2010
- Table 11.8: Spanish Market Share Analysis for POC Fecal Occult Testing Devices, 2010
- Table 11.9: U.K. Market Share Analysis for POC Fecal Occult Testing Devices, 2010
- Table 11.10: Benelux Market Share Analysis for POC Fecal Occult Testing Devices, 2010
- Table 11.11: Scandinavian Market Share Analysis for POC Fecal Occult Testing Devices, 2010
- Table 11.12: Rest-of-Europe Market Share Analysis for POC Fecal Occult Testing Devices, 2010
- Table 12.1: Selected POC Cholesterol Testing Devices, 2011
- Table 12.2: European Revenue Forecasts for POC Cholesterol Testing Products Market, 2007-2017
- Table 12.3: National Revenue Forecasts by Country for POC Cholesterol Testing Products Market,
- 2007-2017
- Table 12.4: European Market Share Analysis for POC Cholesterol Testing Products Market, 2010
- Table 12.5: French Market Share Analysis for POC Cholesterol Testing Products Market, 2010
- Table 12.6: German Market Share Analysis for POC Cholesterol Testing Products Market, 2010
- Table 12.7: Italian Market Share Analysis for POC Cholesterol Testing Products Market, 2010
- Table 12.8: Spanish Market Share Analysis for POC Cholesterol Testing Products Market, 2010
- Table 12.9: U.K. Market Share Analysis for POC Cholesterol Testing Products Market, 2010
- Table 12.10: Benelux Market Share Analysis for POC Cholesterol Testing Products Market, 2010
- Table 12.11: Scandinavian Market Share Analysis for POC Cholesterol Testing Products Market, 2010
- Table 12.12: Rest-of-Europe Market Share Analysis for POC Cholesterol Testing Products Market, 2010
- Table 13.1: Abaxis, Inc. Net Sales by Business Sector, 2008-2010
- Table 13.2: Abaxis, Inc. Net Sales by Geographic Region, 2008-2010
- Table 13.3: Abbott Laboratories Net Sales by Business Sector, 2008-2010
- Table 13.4: Abbott Laboratories Net Sales by Geographic Region, 2008-2010
- Table 13.5: Alere, Inc. Net Sales by Business Sector, 2008-2010
- Table 13.6: Alere, Inc. Net Sales by Geographic Region, 2008-2010
- Table 13.7: Bayer AG Net Sales by Business Sector, 2008-2010
- Table 13.8: Bayer AG Net Sales by Geographic Region, 2008-2010
- Table 13.9: Johnson & Johnson Net Sales by Major Medical and Diagnostics Businesses, 2008-2010
- Table 13.10: Roche Group Net Sales by Business Sector, 2008-2010
- Table 13.11: Roche Group Net Sales by Geographic Region (Pharmaceuticals), 2009 and 2010
- Table 13.12: Roche Group Net Sales by Sub-Division (Diagnostics), 2008-2010
- Table 13.13: Medtronic Net Sales by Segment, 2008-2010
- Table 13.14: Danaher Corporation Net Sales by Business Sector, 2008-2010
- Table 13.15: Danaher Corporation Net Sales by Geographic Region, 2008-2010
More Europe Point-of-Care Reports
European Point of Care Testing Market by
Frost & Sullivan
This study focuses on the point of care testing market in Western Europe pertaining to the products that are currently in use and for near ...
European Market for Continuous Glucose Monitoring by
Frost & Sullivan
This research service provides a qualitative and quantitative analysis for continuous glucose monitoring market in Europe. The rise in aging population and increased occurrence of ...
European Lab-on-chip and Microfluidics Markets by
Frost & Sullivan
This research service gives a detailed analysis of the lab-on-chip and microfluidics market in Europe from 2005-2015.
...
European Point of Care (POC) Infectious Disease Market by
Frost & Sullivan
This research service gives a detailed analysis of the European point of care (POC) infectious disease market from ...
The Emerging European Molecular POC Testing Markets by
Frost & Sullivan
This Frost & Sullivan research service titled The Emerging European Molecular POC Testing Markets analyses the POC molecular and infectious disease markets, their competitive structure ...
See all reports like this >>
More Europe Reports
A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
See all reports like this >>
Share this report
Other tasks Related Markets Point-of-Care Reports- 2012 Overview of the Laboratory and POC Hemostasis Diagnostic Markets: Facilities, Test Volumes, Sales Forecasts, and Key Player Market Shares
- 2012 World Hospital and Point-of-Care Coagulation Testing Market Outlook: Facilities, Test Volumes, Sales Forecasts, and Key Player Market Shares
- Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
- The 2012 Hematology and Flow Cytometry Instrumentation Review: Operating Characteristics, Features and Selling PricesOf 60 High-, Medium-, and Low-Volume/POC Analyzers
- The 2012 Global Overview of the Laboratory and POC Coagulation Testing Markets: Facilities, Test Volumes, Sales Forecasts, and Key Player Market Shares
Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
